Oppenheimer Asset Management Inc. Eli Lilly & CO Transaction History

Oppenheimer Asset Management Inc.

$6.65 Billion
Q1 2024

A detailed history of Oppenheimer Asset Management Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 36,239 shares of LLY stock, worth $32.9 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

36,239

Previous 40,232 9.92%

Holding current value

$32.9 Million

Previous $23.5 Million 20.21%

% of portfolio

0.42%

Previous 0.33%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$592.2 - $792.28 $2.36 Million - $3.16 Million	-3,993 Reduced 9.92%	36,239 $28.2 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $88,231 - $104,013	-168 Reduced 0.42%	40,232 $23.5 Million
Q3 2023 Nov 07, 2023	SELL	$434.7 - $599.3 $918,955 - $1.27 Million	-2,114 Reduced 4.97%	40,400 $21.7 Million
Q2 2023 Aug 02, 2023	SELL	$350.74 - $468.98 $288,308 - $385,501	-822 Reduced 1.9%	42,514 $19.9 Million
Q1 2023 May 10, 2023	BUY	$310.63 - $364.82 $440,162 - $516,949	1,417 Added 3.38%	43,336 $14.9 Million

Q4 2022 Feb 06, 2023	SELL	$321.55 - $374.67 $321,871 - $375,044	-1,001 Reduced 2.33%	41,919 $15.3 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $6.66 Million - $7.59 Million	-22,455 Reduced 34.35%	42,920 $13.9 Million
Q2 2022 Aug 08, 2022	SELL	$278.73 - $327.27 $6.17 Million - $7.24 Million	-22,129 Reduced 25.29%	65,375 $21.2 Million
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $3.77 Million - $4.68 Million	16,051 Added 22.46%	87,504 $25.1 Million
Q4 2021 Feb 02, 2022	SELL	$224.85 - $279.04 $174,483 - $216,535	-776 Reduced 1.07%	71,453 $19.7 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $3.67 Million - $4.52 Million	-16,561 Reduced 18.65%	72,229 $16.7 Million
Q2 2021 Aug 03, 2021	BUY	$180.55 - $233.54 $900,583 - $1.16 Million	4,988 Added 5.95%	88,790 $20.4 Million
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $2.92 Million - $3.78 Million	-17,791 Reduced 17.51%	83,802 $15.7 Million
Q4 2020 Feb 11, 2021	SELL	$130.46 - $172.63 $651,778 - $862,459	-4,996 Reduced 4.69%	101,593 $17.2 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $3.67 Million - $4.25 Million	-25,121 Reduced 19.07%	106,589 $15.8 Million
Q2 2020 Aug 11, 2020	SELL	$136.42 - $164.18 $7.5 Million - $9.03 Million	-55,009 Reduced 29.46%	131,710 $21.6 Million
Q1 2020 May 08, 2020	SELL	$119.05 - $147.35 $925,494 - $1.15 Million	-7,774 Reduced 4.0%	186,719 $25.9 Million
Q4 2019 Feb 07, 2020	SELL	$106.92 - $132.43 $3.81 Million - $4.72 Million	-35,624 Reduced 15.48%	194,493 $25.6 Million
Q3 2019 Oct 31, 2019	SELL	$106.79 - $116.16 $790,032 - $859,351	-7,398 Reduced 3.11%	230,117 $25.7 Million
Q2 2019 Aug 09, 2019	SELL	$110.79 - $129.32 $976,946 - $1.14 Million	-8,818 Reduced 3.58%	237,515 $26.3 Million
Q1 2019 Apr 24, 2019	SELL	$111.31 - $131.02 $6.63 Million - $7.81 Million	-59,605 Reduced 19.48%	246,333 $32 Million
Q4 2018 Jan 30, 2019	SELL	$105.9 - $118.64 $213,494 - $239,178	-2,016 Reduced 0.65%	305,938 $35.4 Million
Q3 2018 Oct 26, 2018	BUY	$85.86 - $107.31 $571,398 - $714,148	6,655 Added 2.21%	307,954 $33 Million
Q2 2018 Aug 10, 2018	SELL	$75.7 - $86.88 $1.35 Million - $1.55 Million	-17,897 Reduced 5.61%	301,299 $25.7 Million
Q1 2018 May 09, 2018	BUY	$74.21 - $87.6 $341,514 - $403,135	4,602 Added 1.46%	319,196 $24.7 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $24.2 Million - $26.9 Million	314,594	314,594 $26.9 Million

Others Institutions Holding LLY

# of Institutions

3,721

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $862B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.

Account

Oppenheimer Asset Management Inc. Eli Lilly & CO Transaction History